Stay updated on RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    This updates the displayed interface revision/version of the ClinicalTrials.gov record history page from v3.5.0 to v3.5.3 without changing the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-26T08:21:56.000Z thumbnail image
  2. Check
    17 days ago
    Change Detected
    Summary
    Eligibility and Study Status sections were added to the record on 2026-04-08. A related update occurred on 2026-04-06, and a prior version was removed on 2024-11-07.
    Difference
    0.4%
    Check dated 2026-04-11T21:35:34.000Z thumbnail image
  3. Check
    39 days ago
    Change Detected
    Summary
    Revision v3.5.0 has been added to the history. Revision v3.4.3 has been removed from the history.
    Difference
    0.1%
    Check dated 2026-03-21T09:11:28.000Z thumbnail image
  4. Check
    53 days ago
    Change Detected
    Summary
    - Added revision entry v3.4.3 to the record history, replacing v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-06T18:48:40.000Z thumbnail image
  5. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1 from the page history.
    Difference
    0.1%
    Check dated 2026-02-13T11:47:06.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    A new revision entry v3.4.1 was added and v3.4.0 removed in the record history, indicating a metadata update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T14:24:16.000Z thumbnail image

Stay in the know with updates to RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page.